New Dye-Based imaging could help surgeons spot bone problems early

NCT ID NCT06793644

Recruiting now Diagnosis Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special dye called ICG, used with a new imaging device, can help surgeons see how healthy a patient's bone is during surgery. Ten adults with open fractures or bone infections will receive the dye and be imaged. The goal is to see if this technique can predict healing and reduce the need for repeat surgeries or infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Indocyanine green (ICG) dye
What this could lead to: If successful, this imaging method could help surgeons better predict bone healing and reduce complications like infections or unplanned reoperations.
What could go wrong: This is a very small early study with only 10 participants, so results may not apply broadly. The imaging is still experimental and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRACTURES, BONE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Accidental Injuries bone fracture Infections injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRACTURES, BONE TRAUMA INJURY

Contacts and locations

Locations

Dartmouth-Hitchcock Medical Center
RECRUITING

Lebanon, New Hampshire, 03756, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.